Bevacizumab 1.25 Mg/0.05 Ml recall
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J…
Why was Bevacizumab 1.25 Mg/0.05 Ml recalled?
Defective Delivery System: difficult to express
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 190212AB BUD: 5/13/2019
- Product
- BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J…
- Recalling firm
- Pacifico National, Inc. dba AmEx Pharmacy
- Quantity
- 249 syringes
- Distribution
- Nationwide in the US
- Recall date
- May 8, 2019
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)